Adverse Event Reporting Included In Draft Electronic Health Record Standards
This article was originally published in The Pink Sheet Daily
Executive Summary
A draft proposal for stage 3 of standards that health care professionals must meet to demonstrate meaningful use of electronic health records includes an adverse event reporting requirement. Janet Woodcock has highlighted adverse event reporting as an area where the agency hopes to interface with EHRs.
You may also be interested in...
PDR Network Following FDA Wishlist In Program That Verifies EHRs Have Drug Safety Operations
PDR Network offers a certification program for electronic health records that is focused on drug safety. EHR vendors that demonstrate certain functions will be able to include a “PDR Certified” logo on their websites and other marketing materials, acknowledging a number of features FDA wants to see incorporated into EHRs.
EHRs Become A Stronger Research Tool Under Proposed Stage 2 Meaningful Use Rule
Use of electronic health records to report data to disease registries, for both cancer and non-cancer conditions, becomes an optional objective for providers to demonstrate “meaningful use” of EHRs under CMS’ proposed stage 2 requirements. An objective to identify patients for potential research opportunities also carries over to the stage 2 proposal.
EHRs A Tool For Drug Label Communications, Adverse Event Reporting And Adherence – FDA’s Woodcock
FDA’s vision for electronic health records is being incorporated into a new application launched by PDR Network.